ORTEXORTEX News
Tracking PGC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
PG
Trader NotePGC

PGC Holds Its Ground After Q3, But Shorts Are Still Building

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 18:45

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Peapack-Gladstone Financial has just published its Q3 earnings and the stock is holding near multi-month highs, yet the short-side conviction that built into the print has not unwound.

Short interest tells the most compelling story this week. Bearish positioning climbed 36% over the past month to 7.4% of the free float, with the bulk of that move arriving in the past week alone, up nearly 6%. The official FINRA settlement figure puts days to cover at almost 12, a meaningful overhang for a stock of this size. What makes the setup unusual is that the borrow market is under no strain at all: availability runs at roughly 1,542% of outstanding short interest, meaning lenders have far more shares available than are currently borrowed. Cost to borrow has risen about 26% over the past week to 0.55%, still low in absolute terms, but the direction is consistently upward. The ORTEX short score has crept higher in every session since October 14, reaching 56.1, its highest point in the observation window. Taken together, the data describes a deliberate, unhurried build in bearish positioning rather than a panic or a forced cover.

Options positioning has nudged more defensive since the earnings date. The put/call ratio is running at 0.21, roughly 1.7 standard deviations above its 20-day average of 0.15 and close to the 52-week high of 0.29. That is still a relatively call-heavy market in absolute terms, but the shift over the past two weeks is notable: the PCR was as low as 0.12 in late September. Traders appear to be adding modest downside protection even as the stock itself gained 4.6% on the week to close at $45.91.

The Street remains constructive, though the most recent analyst moves are from August and are approaching the edge of what should be treated as current. Keefe, Bruyette and Woods reiterated Outperform in early August with a $56 target; Piper Sandler lifted its target to $58 with an Overweight rating in late July, the highest on the Street. Raymond James carries a Strong Buy with a $55 target. The consensus mean of $56 implies roughly 22% upside from current levels, a gap that likely explains why institutional buyers have been active. BlackRock added 126,000 shares in the quarter ending September 30, bringing its stake to 9.1% of the company. State Street and Geode each added material positions in the same period. The price-to-book multiple of 1.03 and a PE of around 10 keep the stock in value territory for a bank with nine consecutive quarters of growing assets and deposits, as confirmed by FDIC call report data.

Insider activity offers a mild counterpoint to institutional enthusiasm. The 90-day net figure shows insiders sold roughly $448,000 more than they bought, with several EVP and SEVP-level sales filed in September. None were made under a 10b5-1 plan. The most recent buy of note was CEO Douglas Kennedy's $398,000 open-market purchase in late March, when the stock was trading around $35. At $45.91 today, insiders who bought in March are sitting on a meaningful gain, which partly contextualises the subsequent selling.

On the company's own balance sheet data, FDIC call reports show total assets and total deposits have each grown for nine straight quarters, reaching $7.96 billion and $7.06 billion respectively as of the June period. The lead status for the net income series remains untested, so no inference about the direction of the Q3 print can be drawn from that dataset alone.

What to watch now is whether short interest continues to rise in the days after the earnings release, or whether bearish positioning starts to unwind as results are digested, with the next scheduled earnings date not until late January 2027.

Stocks in this article

See the live data behind this article on ORTEX.

Open PGC on ORTEX →

How this article was generated

Generated
28 Oct 2026, 18:46
Data as of
28 Oct 2026, 18:45
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.